This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Resolved

MYLAN-NIFEDIPINE EXTENDED RELEASE

MYLAN PHARMACEUTICALS ULC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MYLAN-NIFEDIPINE EXTENDED RELEASE in Canada?

Yes. MYLAN-NIFEDIPINE EXTENDED RELEASE 30MG has an active shortage reported to Health Canada (last updated October 6, 2026).

Why is MYLAN-NIFEDIPINE EXTENDED RELEASE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MYLAN-NIFEDIPINE EXTENDED RELEASE be available again?

The manufacturer's estimated resolution date is November 24, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength30MG

Report last updated2026-08-10

Checked by MedShort2026-11-12

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02349167

Strength

30MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

NIFEDIPINE

Tier

Unrated

Last Updated

2026-08-10

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

MYLAN-NIFEDIPINE EXTENDED RELEASE has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-06

Active Shortage

Disruption of the manufacture of the drug.

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

40MG · DIN 02257963

10MG · DIN 02257955

DIN 02388138

DIN 02388146